| Author/Editor | Škof, Erik; Špan, Matjaž; Keber, Irena | |
| Title | Secondary prevention in patients several years after myocardial infarction: comparison of an outpatient and an inpatient rehabilitation programme | |
| Type | članek | |
| Source | J Cardiovasc Risk | |
| Vol. and No. | Letnik 8, št. 3 | |
| Publication year | 2001 | |
| Volume | str. 119-26 | |
| Language | eng | |
| Abstract | Objective: To compare the effectiveness of secondary preventive measures in patients after myocardial infarction participating in an outpatient rehabilitation programme at a university hospital with those of an inpatient programme in community hospitals. Design: Cross-sectional study of patients several years after myocardial infarction. Methods: Seven hundred patients who survived myocardial infarction in the period from 1 January 1989 to 31 December 1995 were chosen from archives of the university hospital (350 patients) and from archives of two community hospitals (350 patients). The patients from the university hospital attended an outpatient rehabilitation programme, while the patients from the community hospitals attended an inpatient rehabilitation programme. The data were obtained by questionnaire, clinical examination and laboratory blood analyses. Results: One hundred and eighty patients attending an outpatient and 140 patients attending an inpatient rehabilitation programme responded to the invitation. Among those who were smokers at the time of myocardial infarction, 91% of patients from the outpatient programme versus 77% of patients from the inpatient programme (P <0.05) gave up smoking and were still non-smokers; 69% versus 48% (P < 0.05) had a lipid-modified diet; 21% versus 36% (P < 0.05) were obese (BMI > 30 kg/m2). Blood pressure > 140/90 mmHg was found in 21% versus 58% (P < 0.05); total cholesterol > 5.0 mmol/l in 67% versus 87% (P < 0.05); and fasting glucose > 5.6 mmol/l in 43% versus 63% (P < 0.05) of patients from the outpatient and the inpatient programmes, respectively. Among prophylactic drug treatments higher usage of beta-blocking agents (56% versus 36%; P < 0.05) and lipolytic agents (43% versus 23%; P < 0.05) and no significant difference in usage of antiplatelet drugs (Abstract truncated at 2000 characters). | |
| Descriptors | MYOCARDIAL INFARCTION SLOVENIA RISK FACTORS PROGRAM EVALUATION PREVALENCE SEX FACTORS AGE FACTORS INPATIENTS DIABETES MELLITUS CROSS-SECTIONAL STUDIES CHOLESTEROL BODY MASS INDEX BLOOD PRESSURE ANTILIPEMIC AGENTS ANTIHYPERTENSIVE AGENTS AMBULATORY CARE |